High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.
暂无分享，去创建一个
T. Naoe | K. Matsuo | R. Ohno | N. Emi | M. Takeuchi | I. Jinnai | Y. Miyazaki | Tohru Kobayashi | S. Miyawaki | H. Akiyama | Y. Ueda | S. Ohtake | F. Yagasaki | A. Maruta | M. Yanada | J. Takeuchi | N. Usui | I. Sugiura